Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Gepotidacin Powder vs Tablet in Healthy Adults
NCT05271799Phase 1Completed
- Sponsor
- GSK
- Start
- Mar 2022
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of gepotidacin in urinary tract infection (UTI) and gonorrhea (2 arms), sponsored by GSK. Primary endpoints: Area under the concentration-time curve from time zero extrapolated to infinite time at 48 hours, Area under the concentration-time curve from time zero to the last quantifiable concentration at 48 hours and 1 more. Started Mar 2022; status: completed.
02
Drugs
gepotidacin
03
Conditions
urinary tract infection (UTI)gonorrhea
Beyond the preview
Go deeper on NCT05271799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05271799.